about
Antipsychotic-induced hyponatraemia: a systematic review of the published evidenceMeta-analysis of efficacy and safety of second-generation dihydropyridine calcium channel blockers in heart failure.Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.Criteria for drug selection in frail elderly persons.Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-cPsychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly.Age-related decline in autonomic control of blood pressure: implications for the pharmacological management of hypertension in the elderly.Adherence with Dosing Guideline in Patients with Impaired Renal Function at Hospital DischargeFluctuation of the renal function after discharge from hospital and its effects on drug dosing in elderly patients--study protocolHypothermia following antipsychotic drug use.Relationship between polypharmacy and underprescribing.Usual care and management of fall risk increasing drugs in older dizzy patients in Dutch general practiceCurrent and future therapy in Alzheimer's disease.Renal function assessment in older adultsSystematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review.Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic review.Rating scales to measure side effects of antipsychotic medication: A systematic review.Antipsychotic drug use associated with urinary tract infections in older women.Relationship between internal risk factors for development of decubitus ulcers and the blood flow response following pressure load.Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study.Do amyloid-lowering strategies work clinically?Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study.Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are needed.Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial).Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners.Antipsychotic drug use and the risk of venous thromboembolism in elderly patients.Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approach.Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study.Reasons for discontinuation of medication during hospitalization and documentation thereof: a descriptive study of 400 geriatric and internal medicine patients.Effect of a discharge medication intervention on the incidence and nature of medication discrepancies in older adults.Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: a multi-centre double-blind randomised controlled clinical trial.Advanced Age and Female Sex As Risk Factors for High Anion Gap Metabolic Acidosis After a Drug Interaction Between Paracetamol and Flucloxacillin: A Case Series.Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin.The Systematic Tool to Reduce Inappropriate Prescribing (STRIP): Combining implicit and explicit prescribing tools to improve appropriate prescribing.Prophylactic Use of Haloperidol and Changes in Glucose Levels in Hospitalized Older Patients.
P50
Q28270769-6BA65D64-3980-4949-8EB5-4A82CE3EC831Q31942459-6F30B71C-AF6E-4124-9899-13B30F72A2B8Q33162113-C03FE0C2-203D-4C65-A00E-6D6E28CDB9E7Q33889859-D6F1A9CE-BE18-48EA-BBE0-EA2E6ACAC1CBQ34165538-A19F638E-10F1-469A-9AE0-AA50020A8219Q34647908-41D98AC5-E400-480D-B80D-A29794E52056Q35107700-8885FF0A-0647-46A8-B69B-99ADD1699FB9Q35656596-53F7640B-A451-4DF2-8EE6-97FB05D91BD7Q35819902-16703476-98DD-4DB7-AF0A-1D7C029C52FFQ35881044-CE2906A8-CDAE-472A-B501-5B660A2E9305Q36536061-EF91529A-B712-4440-9637-C79752572D84Q37160944-8D5436CC-CF4C-4266-A7CA-12EC7B62D46DQ37165703-C338A031-590E-4F93-ACA0-A2FEAAF80976Q37219063-49A5239B-EE85-48AA-8B61-6FB221C82832Q37675728-7060264B-F7E7-4735-BFDA-C49A093A4327Q38010283-E498D945-E00C-4152-8E3F-4D6DB9F38E3BQ38235954-6CAFE343-8582-4B58-902D-36E03D0A9DB2Q38544223-30A696CA-7B9D-4580-8AF2-F022B438E1BCQ38920220-9D29C19B-6243-4AAA-AC4D-4679F1B977D3Q39417192-B7B0D663-4617-4B2C-BBCE-236225F813EAQ40151740-7ED0E011-3B8B-42FE-85F5-C13EB05796F5Q40339199-C72B4704-9303-4C6F-B22C-0757AB769484Q41175983-EBF4A74F-6A49-4099-BDA0-40F43D23B7C0Q41436212-D10BD107-3578-4F53-A33A-F3D1A0B9EC6EQ41477917-10CEF0DD-1354-488A-83AC-873638E411E8Q42958109-0834FAB5-59C0-47A3-A5BE-C58614AD46BFQ43018945-AC53A455-C7C3-4D94-A4E0-1E79BF43ED9CQ43018949-A0997513-2F49-4F0A-8236-4D5247D5F729Q43147475-AF4D597A-B0A0-42D4-985E-C25E570264B4Q43936519-28B220E7-1ADF-4F7A-9DBE-02431BFE073DQ43939770-88C2D481-6F4B-4A8C-9607-60DFAB6FB8B1Q44166618-EAB860DD-7210-494B-88A3-E0019F6AEB53Q44393681-7D3953CF-02B6-4F8D-8AB7-083610A0F441Q45108076-F480F1CC-A930-4A26-88B3-53689D4F917BQ45349476-08ADDA87-FE00-46AC-AD91-DDF92FE98A1DQ47850114-D8E75B03-F4D8-4855-A6E1-D32622B2E44DQ47976780-09500560-1E2E-4097-9CD6-01E925DFC8B9Q48278624-80DAC8F8-3932-495E-94EA-D3C6CA10EBBDQ48291295-8C68F4DC-1646-4815-88D4-F4AC1D7A1D51Q50052730-9A041CFD-379E-4BB0-9B77-52CFBE4983FA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rob J van Marum
@ast
Rob J van Marum
@en
Rob J van Marum
@es
Rob J van Marum
@nl
type
label
Rob J van Marum
@ast
Rob J van Marum
@en
Rob J van Marum
@es
Rob J van Marum
@nl
prefLabel
Rob J van Marum
@ast
Rob J van Marum
@en
Rob J van Marum
@es
Rob J van Marum
@nl
P106
P1153
6603800001
P31
P496
0000-0003-4292-532X